Deletion of the PMP22 gene and hereditary neuropathy with liability to pressure palsies

Current Opinion in Neurology

Volumn 9, Issue 5, 1996, Pages 348-354

  Pareyson, Davide ^a   Taroni, Franco ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN;

CHROMOSOME 17P; CHROMOSOME REARRANGEMENT; FRAMESHIFT MUTATION; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION; GENOTYPE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MEIOSIS; NEUROPATHY; NONHUMAN; NONSENSE MUTATION; PARALYSIS; PATHOGENESIS; PHENOTYPE; PROTEIN LOCALIZATION; REVIEW;

EID: 0029856839     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199610000-00006     Document Type: Review

References (58)

1. Windebank AJ: Inherited recurrent focal neuropathies. In Peripheral neuropathy, edn 3. Edited by Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, Philadelphia: WB Saunders; 1993:1137-1148.
2. Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Disteche CM, Bird TD: DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993, 72:143-151.
3. Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA et al.: DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991, 66:219-232.
4. De Jong JGY: About families with a hereditary disposition to compression of the nerves correlated with migraine [In Dutch]. Psychiatr Neurol Bl 1947, 50:60-76.
5. Lupski JR, Chance PF, Garcia CA: Inherited primary peripheral neuropathies. Molecular genetics and clinical implications of CMT1A and HNPP. JAMA 1993, 270:2326-2330.
6. Chance PF, Abbas N, Lensch MW, Pentao L, Roa BB, Patel PI, Lupski JR: Two autosomal dominant neuropathies from reciprocal DNA duplication/ deletion of a region on chromosome 17. Hum Mol Genet 1994, 3: 223-228.
7. Lorenzetti D, Pareyson D, Sghirlanzoni A, Roa BB, Abbas NE, Pandolfo M, • Di Donate S, Lupski JR: A 1.5Mb deletion in 17p11.2-p12 is frequently observed in Italian families with hereditary neuropathy with liability to pressure palsies. Am J Hum Genet 1995, 56:91-98. First large series of patients analysed by multiple molecular methods including direct detection of the HNPP junction fragments by pulse-field gel electrophoresis and CMT1A-REP dosage analysis by Southern blot.
8. LeGuern E, Gouider R, Ravisé N, Lopes J, Tardieu S, Gugenheim M, Abbas N, Bouche P, Agid Y, Brice A: A de novo case of hereditary neuropathy with liability to pressure palsies (HNPP) of maternal origin: a new mechanism for deletion in 17p11.2? Hum Mol Genet 1996, 5:103-106.
9. Suter U, Snipes GJ: Peripheral myelin protein 22: facts and hypothesis. • J Neurosci Res 1995, 40:145-151. Authoritative and exhaustive review on the PMP22 gene and protein structure and function. Includes recent advances and discussion of similarities between PMP22 and PLP.
10. ••]
11. ••]
12. ••] report the unusual presence within the repeats of mariner insect transposon-like element, a transposon-like sequence of insect origin. Mariner insect transposon-like element is not likely to mediate recombination because it appears not to be functionally active.
13. Hartl DL: The most unkindest cut of all. Nature Genet 1996, 12:227-229.
14. Oosumi T, Belknap WR, Garlick B: Mariner transposons in humans [Letter]. Nature 1995, 378:672.
15. Robertson HM, Zumpano KL, Lohe AR, Hartl DL: Reconstructing the ancient mariners of humans. Nature Genet 1996, 12:360-361
16. Le Guern E, Sturtz F, Gugenheim M, Gouider R, Bonnebouche C, Ravisé N, Gonnaud P-M, Tardieu S, Bouche P, Chazot G et al.: Detection of deletion within 17p11.2 in 7 French families with hereditary neuropathy with liability to pressure palsies (HNPP). Cytogenet Cell Genet 1994, 65: 261-264.
17. Reisecker F, Leblhuber F, Lexner R, Radner G, Rosenkranz W, Wagner K: A sporadic form of hereditary neuropathy with liability to pressure palsies: clinical, electrodiagnostic, and molecular genetic findings. Neurology 1994, 44:753-755.
18. Verhalle D, Löfgren A, Nelis E, Dehaene I, Theys P, Lammens M, Dom R, Van Broeckhoven C, Robberecht W: Deletion In CMT1A locus on chromosome 17p11.2 in hereditary neuropathy with liability to pressure palsies. Ann Neurol 1994, 35:704-708.
19. Mariman ECW, Gabreëls-Festen AAWM, van Beersum SEC, Valentijn LJ, Baas F, Bolhuis PA, Jongen PJH, Ropers HH, Gabreëls FJM: Prevalence of the 1.5 Mb 17p deletion In families with hereditary neuropathy with liability to pressure palsies. Ann Neurol 1994, 36:650-655.
20. Silander K, Halonen P, Sara R, Kalimo H, Falck B, Savontaus M-L: DNA analysis in Finnish patients with hereditary neuropathy with liability to pressure palsies (HNPP). J Neurol Neurosurg Psychiatry 1994, 57:1260-1262.
21. Mandich P, James R, Nassani S, Defferrari R, Bellone E, Mancardi GL, Schenone A, Abbruzzese M, Rocchi M, Ajmar F, Archidiacono N: Molecular diagnosis of hereditary neuropathy with liability to pressure palsies (HNPP) by detection of 17p11.2 deletion in Italian patients. J Neurol 1995, 242:295-298.
22. Gonnaud PM, Sturtz F, Fourbil Y, Bonnebouche C, Tranchant C, Warter JM, Chazot G, Bady B, Vial C, Brechard AS, Vandenberghe A: DNA analysis as a tool to confirm the diagnosis of asymptomatic hereditary neuropathy with liability to pressure palsies (HNPP) with further evidence for the occurrence of de novo mutations. Acta Neurol Scand 1995, 92:313-318.
23. Hardmg AE: From the syndrome of Charcot, Marie and Tooth to disorders •• of peripheral myelin proteins. Brain 1995, 118:809-818. Exhaustive review on Charcot-Marie-Tooth disease and HNPP, with an historical resume of past and recent advances in the field. Contains very useful and updated clinical and biological informations. The author proposes a new approach to the classification of hereditary neuropathies taking into account the recent findings in biology and genetics.
24. Onishi A, Li L-Y, Fukushima Y, Mori T, Mori M, Endo C, Yoshimura T, Sonobe M, Flandermeyer R, Lebo RV: Asian hereditary neuropathy patients with peripheral myelin protein-22 gene aneuploldy. Am J Med Genet 1995, 59:51-58.
25. LeGuern E, Gouider R, Lopes J, Abbas N, Gugenheim M, Tardieu S, Ravisé N, Léger J-M, Vallat J-M, Bouche P, Agid Y, Brice A, and the French CMT collaborative research group: Constant rearrangement of the CMT1A-REP sequences in HNPP patients with a deletion In chromosome 17p11.2: a study of 30 unrelated cases. Hum Mol Genet 1995, 4:1673-1674.
26. Amato AA, Gronseth GS, Callerame KJ, Kagan-Hallet KS, Bryan WW, Barohn RJ: Tomaculous neuropathy: a clinical and electrophysiological study In patients with and without 1.5Mb deletions in chromosome 17p11.2. Muscle Nerve 1996, 19:16-22.
27. •]
28. •]
29. Pareyson D, Scaioli V, Taroni F, Botti S, Lorenzetti D, Solari A, Ciano C, • Sghirlanzoni A: Phenotypic heterogeneity in hereditary neuropathy with liability to pressure palsies associated with chromosome 17p11.2-12 deletion. Neurology 1996, 46:1133-1137. Interesting papers reporting clinical-molecular correlations and the variable phenotypic expression of deletion-associated HNPP. Each presents large series of patients thoroughly investigated from both the clinical and electrophysiological point of view.
30. Barbieri F, Santangelo R, Crisci C, Ragno M, Perretti A, Santoro L: A family with tomacutous neuropathy mimicking Charcot-Marie-Tooth disease. Clin Neurol Neurosurg 1990, 92:289-294.
31. Andreadou E, Yapijakis C, Paraskevas GP, Stavropoulos P, Karadimas C, Zis VP, Davaki P, Karandreas N, Rentzos M, Tsakanikas C et al.: Hereditary neuropathy with liability to pressure palsies: the same molecular defect can result in diverse clinical presentation. J Neurol 1996, 243:225-230.
32. Gouider R, Le Guem E, Emile J, Tardieu S, Gabon F, Samid M, Weissenbach J, Agid Y, Bouche P, Brice A: Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: two distinct clinical, electrophysiologic, and genetic entities. Neurology 1994, 44:2250-2252.
33. Chance PF, Lensch MW, Lipe H, Brown RH Sr., Brown RH Jr., Bird TD: Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: two distinct genetic disorders. Neurology 1994, 44:2253-2257.
34. Windebank AJ, Schenone A, Dewald GW: Hereditary neuropathy with liability to pressure palsies and inherited brachial plexus neuropathy - two genetically distinct disorders. Mayo Clin Proc 1995, 70:743-746.
35. Pellegrino JE, Rebbeck TR, Brown MJ, Farlow MR, Brown RH, Busis NA, Caress J, Upe H, Bird TD, Chance PF: Genetic analysis in hereditary neuralgic amyotrophy [Abstract]. Neurology 1996, 46:A271.
36. Felice KJ: Acute anterior interosseous neuropathy in a patient with hereditary neuropathy with liability to pressure palsies: a clinical and electromyographic study. Muscle Nerve 1995, 18:1329-1331.
37. Pareyson D, Solari A, Scaioli V, Ciano C, Botti S, Taroni F, Sghirlanzoni A: Tomaculous neuropathy in patients with acute painless mononeuropathy/plexopathy [Abstract]. Neurology 1996, 46:A337-338.
38. Mancardi GL, Mandich P, Nassani S, Schenone A, James R, Defferrari R, Bellone E, Giunchedi M, Ajmar F, Abbruzzese M: Progressive sensory-motor polyneuropathy with tomaculous changes is associated to 17p11.2 deletion. J Neurol Sci 1995, 131:30-34.
39. Uncini A, Di Guglielmo G, Di Muzio A, Gambi D, Sabatelli M, Mignogna T, Tonali P, Marzella R, Finelli P, Archidiacono N, Rocchi M: Differential electrophysiological features of neuropathies associated with 17p11.2 deletion and duplication. Muscle Nerve 1995, 18:628-635.
40. Thomas FP, Lebo RV, Rosoklija G, Ding X-S, Lovelace RE, Latov N, Hays AP: Tomaculous neuropathy in chromosome 1 Charcot-Marie-Tooth syndrome. Acta Neuropathol 1994, 87:91-97.
41. Nicholson GA, Valentijn LJ, Cherryson AK, Kennerson ML, Bragg TL, DeKroon RM, Ross DA, Pollard JD, McLeod JG, Bolhuis PA, Baas F: A frame shift mutation In the PMP-22 gene In hereditary neuropathy with liability to pressure palsies. Nature Genet 1994, 6:263-266.
42. Taroni F, Botti S, Sghirlanzoni A, Botteon G, Di Donato S, Pareyson D: A nonsense mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies (HNPP) not associated with the 17p11.2 deletion [Abstract]. Am J Hum Genet 1995, 57:A229
43. Mariman ECM, Gabreëls-Festen AAWM, van Beersum SEC, Valentijn LJ, Bolhuis PA, Baas F, Ropers HH, Gabreëls FJM: Elucidation of the molecular defect causing a severe type of hereditary neuropathy with liability to pressure palsies (HNPP) In patients lacking the common 1.5 Mb deletion in chromosome 17p [Abstract] Am J Hum Genet 1995, 57:A22.
44. Mariman ECM, Gabreëls-Festen AAWM, van Beersum SEC, Jongen PJ, van de Looij E, Baas F, Bolhuis PA, Ropers HH, Gabreëls FJM: Evidence for genetic heterogeneity underlying hereditary neuropathy with liability to pressure palsies. Hum Genet 1994, 93:151-156.
45. Parmantier E, Cabon F, Braun C, D'Urso D, Müller HW, Zalc B: Peripheral myelin proteln-22 Is expressed in rat and mouse brain and spinal cord motorneurons. Eur J Neurosci 1995, 7:1080-1088.
46. Suter U, Snipes GJ, Schoener-Scott R, Welcher AA, Pareek S, Lupski JR, Murphy RA, Shooter EM, Patel PI: Regulation of tissue-specific expression of alternative peripheral myelin proteln-22 (PMP22) gene transcript by two promoters. J Biol Chem 1994, 269:25795-25808.
47. Baechner D, Liehr T, Hameister H, Altenberger H, Grehl H, Suter U, • Rautenstrauss B: Widespread expression of the peripheral myelin proteln-22 gene (pmp22) In neural and non-neural tissues during murine development J Neurosci Res 1995, 42:733-741. Interesting study on the temporal and spatial expression pattern of PMP22 in mouse embryonic development. Discusses the role of PMP22 in differentiation and morphogenesis.
48. Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C, Müller HW: • Retrovlral-mediated gene transfer of the peripheral myelin protein PMP22 In Schwann cells: modulation of cell growth. EMBO J 1995, 14:1122-1128. An in-vitro study of a dosage-dependent effect of PMP22 on growth of transtected Schwann cells. Provides evidence that PMP22 acts as a negative modulator of growth and delays entry of the quiescent Schwann cell into the cell cycle.
49. Fabbretti E, Edomi P, Brancolini C, Schneider C: Apoptotic phenotype • induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev 1995, 9:1846-1856. Study on the effects of PMP22 overexpression on cell viability. Demonstrates that different PMP22 mutations have a dominant-negative effect and counteract apoptosis induced by overexpression of wild-type PMP22.
50. Griffiths IR, Montague P, Dickinson P: The proteollpid protein gene. • Neuropathol Appl Neurobiol 1995, 21:85-96. Excellent and complete review on the biology and genetics of PLP. The high homology between PLP and PMP22 renders this review particularly important for readers interested in getting deeper insights into myelin protein structure and function.
51. Vallat JM, Sindou P, Preux PM, Tabaraud F, Couratier P, Milor AM, Brice A, Le Guern E: PMP22 immunoreactivity on biopsied sural nerves in Charcot-Marie-Tooth disease 1A and hereditary neuropathy with liability to pressure palsies [Abstract]. Neurology 1996, 46:A338.
52. Gabriel J-M, Erne B, Sghirlanzoni A, Taroni F, Pareyson D, Steck AJ: Genedosage effects in hereditary peripheral neuropathy: expression of PMP22 In CMT1A and HNPP nerve biopsies [Abstract]. J Neurol Sci 1996, 243[suppl 2]:S19.
53. Hanemann CO, Stoll G, D'Urso D, Fricke W, Martin JJ, Van Broeckhoven C, Mancardi GL, Batke I, Müller HW: Perlpheral myelln protein-22 expression In Charcot-Marle-Tooth disease type 1a sural nerve biopsies. J Neurosci Res 1994, 37:654-659.
54. Yoshikawa H, Nishimura T, Nakatsuji Y, Fujimura H, Himoro M, Hayasaka K, Sakoda S, Yanagihara T: Elevated expression of messenger RNA for peripheral myelln protein 22 In blopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1a. Ann Neurol 1994, 35:445-450.
55. Hanemann CO, Stoll G, Müller HW: PMP22 expression in CMT1a neuropathy. Ann Neurol 1995, 37:136.
56. Schenone AE, Nobbio L, Gross L Mandich P, Bellone E, Abbruzzese M, Mancardi GL, Windebank AJ: Peripheral myelin protein 22 Is under-expressed In patients with hereditary neuropathy with llability to pressure palsies [Abstract]. Neurology 1996, 46:A338
57. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U: Hypermyelination •• and demyelinating peripheral neuropathy In Pmp22-deficient mice. Nature Genet 1995, 11:274-280. Important atudy on the first animal model of HNPP generated by gene targeting technology. Mice carrying a null mutation in the Pmp22 gene in homozygous or heterozygous form were clinically, etectrophysiologically. and pathologically investigated. Suggests a crucial function of PMP22 in maintaining myelin thickness and stability and axonal integrity along with an important role in early steps of peripheral nerve myelination.
58. Scherer SS, Chance PF: Myelin genes: getting the dosage right Nature Genet 1995, 11:226-228.